Fundraising Fox
/Companies
Sign in

FerroKin Biosciences

acquired by Shire

San Carlos, US · Founded 2007 · 3 known investors

Find your way into FerroKin Biosciences

Each arrow is one introduction. Sign up to fill in the first one.

311 people can intro you to Hugh

Ask Laura G. Eichorn to introduce you to Hugh Y. Rienhoff, Jr., M.D.

You →Laura · together at FerroKin Biosciences →Hugh

Sign up to find every way you can get introduced to FerroKin Biosciences

  • Your email: who you already know at FerroKin Biosciences, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the FerroKin Biosciences team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Developed a next-generation iron chelator for iron overload in transfusion-dependent anemia; acquired by Shire in 2012.

Biotech

Founders & leadership

FerroKin Biosciences was founded in 2007 by Hugh Y. Rienhoff, Jr., M.D..

HYHugh Y. Rienhoff, Jr., M.D.
Hugh Y. Rienhoff, Jr., M.D.Founder · Chief Executive Officer2006–2012Dr. Rienhoff holds a background in medicine, mathematics, and genetics, and has founded or led multiple biotech companies including FerroKin BioSciences, Imago BioSciences, and Aluco BioSciences. His work translating scientific research into therapeutics has been informed by personal experience identifying a novel genetic syndrome.

Board

MSMarten Steen
Marten SteenBoard Member2010–2012Managing Partner at HealthCap
DH
Dennis Henner, Ph.D.Board director
BE
Bryant E. FongBoard director

Investors · 3

MC Healthcare Ventureslisted by MC Healthcare VenturesCambridge

How we know: MC Healthcare Ventures's portfolio page · Not right? Tell us

Clarus VenturesreportedMenlo Park

How we know: funding news · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$3M disclosed across 1 round · 2012

▶$3MraisedFeb 2012 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Marten SteenDirector
  • Hugh Y. Rienhoff, Jr., M.D.Executive Officer, Director
  • Dennis Henner, Ph.D.Director
  • Bryant E. FongDirector
Offering amount
$6M
Amount sold
$3M
Minimum investment
$1
First sale
Feb 2012
Incorporated
Corporation, Delaware, 2007
Federal exemptions
06
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does FerroKin Biosciences do?
Developed a next-generation iron chelator for iron overload in transfusion-dependent anemia; acquired by Shire in 2012.
Who founded FerroKin Biosciences?
FerroKin Biosciences was founded by Hugh Y. Rienhoff, Jr., M.D. in 2007.
Who are FerroKin Biosciences's investors?
FerroKin Biosciences's investors include HealthCap, MC Healthcare Ventures, Clarus Ventures.
How much funding has FerroKin Biosciences raised?
FerroKin Biosciences has disclosed $3M raised across 1 round.
Who acquired FerroKin Biosciences?
FerroKin Biosciences was acquired by Shire.
Where is FerroKin Biosciences headquartered?
FerroKin Biosciences is headquartered in San Carlos, US.